New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- Cellectis bioresearch
- 8 rue de la Croix Jarry
- Paris , 75013
Cellectis bioresearch’s mission is to provide easy access to Meganucleases and their enabling potential to modify the DNA sequence of a target genome with high precision. Meganucleases are highly specific DNA endonucleases which provide the biotechnology industry with a full set of Genome Customization tools.